Arkaitz Imaz

1.8k total citations
81 papers, 744 citations indexed

About

Arkaitz Imaz is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Arkaitz Imaz has authored 81 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Infectious Diseases, 38 papers in Virology and 21 papers in Emergency Medicine. Recurrent topics in Arkaitz Imaz's work include HIV/AIDS drug development and treatment (54 papers), HIV Research and Treatment (38 papers) and HIV/AIDS Research and Interventions (38 papers). Arkaitz Imaz is often cited by papers focused on HIV/AIDS drug development and treatment (54 papers), HIV Research and Treatment (38 papers) and HIV/AIDS Research and Interventions (38 papers). Arkaitz Imaz collaborates with scholars based in Spain, United States and United Kingdom. Arkaitz Imaz's co-authors include Daniel Podzamczer, Esteban Ribera, Vicenç Falcó, Adrián Curran, Juan Tiraboschi, Jordí Niubó, Peré Domingo, Josep M. Llibre, S Villar del Saz and Bonaventura Clotet and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Arkaitz Imaz

74 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arkaitz Imaz Spain	16	574	390	221	111	54	81	744
Ruth Goodall United Kingdom	16	597 1.0×	370 0.9×	242 1.1×	118 1.1×	29 0.5×	47	893
Daniel Seekins United States	19	532 0.9×	324 0.8×	211 1.0×	161 1.5×	53 1.0×	30	746
Carmen Rodríguez Spain	13	467 0.8×	223 0.6×	361 1.6×	78 0.7×	21 0.4×	19	675
Marcel Stoeckle Switzerland	14	336 0.6×	152 0.4×	169 0.8×	101 0.9×	49 0.9×	54	517
Marita Stevens Belgium	18	659 1.1×	451 1.2×	237 1.1×	143 1.3×	48 0.9×	38	985
Victoria Watson United Kingdom	16	475 0.8×	398 1.0×	144 0.7×	134 1.2×	42 0.8×	32	690
Miguel Goicoechea United States	10	467 0.8×	282 0.7×	129 0.6×	183 1.6×	33 0.6×	24	572
Kati Vandermeulen Belgium	12	651 1.1×	480 1.2×	133 0.6×	177 1.6×	35 0.6×	19	713
Henry Sunpath United States	19	914 1.6×	630 1.6×	245 1.1×	114 1.0×	18 0.3×	47	1.0k
Ross G. Hewitt United States	16	376 0.7×	170 0.4×	205 0.9×	77 0.7×	18 0.3×	34	714

Countries citing papers authored by Arkaitz Imaz

Since Specialization

Citations

This map shows the geographic impact of Arkaitz Imaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arkaitz Imaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arkaitz Imaz more than expected).

Fields of papers citing papers by Arkaitz Imaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arkaitz Imaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arkaitz Imaz. The network helps show where Arkaitz Imaz may publish in the future.

Co-authorship network of co-authors of Arkaitz Imaz

This figure shows the co-authorship network connecting the top 25 collaborators of Arkaitz Imaz. A scholar is included among the top collaborators of Arkaitz Imaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arkaitz Imaz. Arkaitz Imaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niubó, Jordí, Amanda P. Schauer, Sandra Morenilla, et al.. (2025). Cabotegravir and Rilpivirine Concentrations and HIV-1 RNA Suppression in Genital Fluids and Rectum in People with HIV on Long-Acting Intramuscular Cabotegravir Plus Rilpivirine Antiretroviral Therapy. The Journal of Infectious Diseases. 233(2). 261–266.

Buckley, Rosa de Miguel, María Lagarde, José Luís Blanco, et al.. (2025). Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial. Clinical Infectious Diseases. 81(3). 491–498. 1 indexed citations

Saumoy, María, Juan Tiraboschi, Judith Peñafiel, et al.. (2025). Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV. HIV Medicine. 26(6). 849–857. 2 indexed citations

Martín-Iguacel, Raquel, Andreu Bruguera, Jordi Aceitón, et al.. (2024). Major cardiovascular events after COVID-19 in people with HIV. Clinical Microbiology and Infection. 30(5). 674–681. 1 indexed citations

Nomah, Daniel K., Yesika Díaz, Andreu Bruguera, et al.. (2024). Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score–Matched Analysis. Open Forum Infectious Diseases. 11(1). ofad693–ofad693. 2 indexed citations

Niubó, Jordí, Peré Domingo, Adrián Curran, et al.. (2023). Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide. The Journal of Infectious Diseases. 228(7). 919–925.

Rigo‐Bonnin, Raül, et al.. (2023). Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV. Clinica Chimica Acta. 552. 117678–117678. 2 indexed citations

Bayes‐Marin, Ivet, Jorge Palacio‐Vieira, Andreu Bruguera, et al.. (2023). Determinants of Depressive Symptoms in People Living with HIV: Findings from a Population-Based Study with a Gender Perspective. International Journal of Environmental Research and Public Health. 20(4). 3687–3687. 10 indexed citations

Palacio‐Vieira, Jorge, Yesika Díaz, Jordi Aceitón, et al.. (2023). Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort. HIV Medicine. 24(9). 965–978. 4 indexed citations

10.

Santos, José Ramón, Peré Domingo, Joaquín Portilla, et al.. (2023). A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 10(11). ofad542–ofad542. 2 indexed citations

11.

Tiraboschi, Juan, et al.. (2022). Short-term Neuropsychiatric and Body Weight Changes in PatientsSwitching From EVG/Cobi/FTC/TAF to BIC/FTC/TAF (PreEC/RIS69). Current HIV Research. 20(3). 251–254. 3 indexed citations

12.

Imaz, Arkaitz, Mackenzie L. Cottrell, Jordí Niubó, et al.. (2022). Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide. Clinical Infectious Diseases. 75(11). 2012–2015.

13.

Saumoy, María, Isaac Subirana, Arkaitz Imaz, et al.. (2021). Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations. HIV Medicine. 22(7). 581–591. 3 indexed citations

14.

Tiraboschi, Juan, Sujan Dilly Penchala, Laura Else, et al.. (2021). Total and Unbound Doravirine Concentrations and Viral Suppression in CSF. Clinical Infectious Diseases. 74(10). 1855–1858. 5 indexed citations

15.

González‐Serna, Alejandro, Anaïs Corma‐Gómez, Francisco Téllez, et al.. (2021). Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. Journal of Antimicrobial Chemotherapy. 76(9). 2375–2379. 3 indexed citations

16.

Climent, Fina, Arkaitz Imaz, Carlota Gudiol, et al.. (2020). Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome. AIDS. 34(14). 2097–2101. 4 indexed citations

17.

Tiraboschi, Juan, Arkaitz Imaz, Saye Khoo, et al.. (2019). Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56). The Journal of Infectious Diseases. 221(9). 1425–1428. 12 indexed citations

18.

Perales, Celia, Qian Chen, María Eugenia Soria, et al.. (2018). Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant. Infection and Drug Resistance. Volume 11. 2207–2210. 18 indexed citations

19.

Tiraboschi, Juan, Dolors Giralt, Carmen Gómez‐Vaquero, et al.. (2018). Changes in Body Fat Distribution in Antiretroviral-Naive HIV-Positive Individuals Initiating Current ART Regimens. The Journal of Clinical Endocrinology & Metabolism. 104(3). 900–905. 4 indexed citations

20.

Imaz, Arkaitz, Núria Cayuela, Jordí Niubó, et al.. (2014). Short Communication: Focal Encephalitis Related to Viral Escape and Resistance Emergence in Cerebrospinal Fluid in a Patient on Lopinavir/Ritonavir Monotherapy with Plasma HIV-1 RNA Suppression. AIDS Research and Human Retroviruses. 30(10). 984–987. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact